Apoptosis of photoreceptors occurs infrequently in adult retina but can be triggered in inherited and environmentally induced retinal degenerations. The protooncogene bcl-2 is knoWn to be a potent regulator of cell survival in neurons. We created lines oftransgenic mice overexpressing bcl-2 to test for its ability to increase photoreceptor survival. Bcl-2 increased photoreceptor survival in mice with retinal degeneration caused by a defective opsin or cGMP phosphodiesterase. Overexpression of Bcl-2 in normal photoreceptors also decreased the damaging effects of constant light exposure. Apoptosis was induced in normal photoreceptors by very high levels of bcl-2. We conclude that bcl-2 is an important regulator of photoreceptor cell death in retinal degenerations.
Retinitis pigmentosa represents a group of inherited diseases that result in blindness through destruction of rod and cone photoreceptors (PRs). The pathogenesis of these retinal degenerations is largely unexplained, and there are no current therapies. Studies over the past decade have linked retinitis pigmentosa to mutations in genes of the phototransduction cascade, specifically rhodopsin (1), cGMP-phosphodiesterase, and other PR-specific proteins. Environmental factors also cause retinal degeneration, the most common being exposure to intense or constant light. The mechanism by which these genetic or environmental insults lead to PR cell death is unknown. Recent studies have demonstrated a common pathway in several transgenic and naturally occurring animal models of these blinding diseases. In both inherited (2) (3) (4) (5) and light-induced (6) (7) (8) retinal degenerations, PRs die by apoptosis. These animal models correlate well with the pathology observed in human donor retinas affected with retinitis pigmentosa (9, 10) , and apoptosis in PRs has been seen in early stages of human retinitis pigmentosa (11) .
Apoptosis is an active process involving a set of highly conserved gene products (12, 13) . The orchestrated action of these genes leads to fragmentation of nuclear DNA, chromosomal condensation, breakdown of intracellular material, and dissolution of the plasma membrane. The debris is quickly phagocytosed by neighboring cells and produces minimal inflammatory response.
Regulation of apoptosis occurs through cellular genes that control entry into the cell death program. bcl-2 is the best described of these survival-promoting genes. It is a member of a rapidly expanding family of genes that modulate the survival response and is a broad and potent inhibitor of apoptosis in many cell types (14) . In cultured neurons, bcl-2 inhibits cell death caused by many different agents, including growth factor or glucose withdrawal, application of calcium ionophores, membrane peroxidation, and free radical peroxidation. Whether bcl-2 can be effective in countering disease progression in vivo is less clear.
We sought to determine if bcl-2 could interfere with PR apoptosis in three different models of retinal degeneration. We overexpressed bcl-2 in PRs of transgenic mice by using a human bcl-2 expression vector driven by the 5'-flanking region of opsin. We crossed these mice to two lines of mice that carried mutations that modeled inherited retinal degeneration in which different mechanisms trigger apoptosis of PRs. We also crossed the bcl-2 transgenic mice to normal albino mice and exposed these animals to several days of constant light, a condition known to produce apoptotic cell death in PRs.
In the first mQdel, we examined the apoptosis-inhibiting property of bcl-2 in a line of transgenic mice expressing a C-terminal truncated form of rhodopsin (15) . The expression of the mutant opsin causes rapid degeneration, presumably from the inability of the cell to appropriately sort the mutant opsin in the PR cells (16, 17) . PR cell death begins at postnatal day 8 and is complete by postnatal day 21.
In a second series of experiments, we tested the anti-apoptotic function of bcl-2 on retinal degeneration caused by a nonfunctional phosphodiesterase in the rd mouse. In homozygous affected rd mice, degeneration of rod PRs begins on postnatal day 10, with loss of most rod cells by postnatal day 20. There are no surviving rods by 4 weeks of age, but a progressive loss of cones continues for many months (18) . cGMP accumulation in the retina precedes the degeneration and correlates with deficient activity of the rod cGMP-phosphodiesterase.
In a third model, we examined the bcl-2 effect on PR apoptosis in albino mice exposed to sustained illumination. In this light-damage model, 14 days of sustained illumination causes apoptotic cell death in the majority of PRs.
In all three models, overexpression of bcl-2 increased the survival of PRs exposed to an insult known to cause apoptosis. These results strongly support the idea that retinal degenerations may be treated by modulating the entry of PRs into the apoptotic cell death pathway.
MATERIALS AND METHODS
Transgene Construction. The opsin/bcl-2 transgene was made by fusing a O.-75-kb fragment encoding the complete human cDNA of bcl-2 from the pSFFV expression vector (19) to the 4.4-kb KpnI/XhoI mouse rod opsin 5'-flanking region. The splice elements were supplied by the simian virus 40 polyadenylylation signal from pSFFV, producing a 6.4-kb fusion gene construct.
An 11-kb mouse genomic fragment was used to express rhodopsin in rod PRs of transgenic mice. A stop codon was created at residue 334 (TCT to TAA) by using site-directed Proc. Natl. Acad. Sci. USA 93 (1996) 7043 mutagenesis. The transgene construct contained -5 kb of 5' upstream regulatory sequence, all 5 exons and introns, and 1.5 kb of 3' downstream sequence.
Transgenic Mouse Production and Analysis. The truncated opsin and bcl-2 fusion genes were injected into fertile one-cell wild-type B6D2 Fl mouse embryos (The Jackson Laboratories). Founder animals for both transgenic lines were identified by PCR. The oligonucleotide pair used for PCR screening for the bcl-2 transgene was as follows: amplifying a transgene fragment using the primers Bcl-2, 5'-CCC TGT TCT CCC AGC GTG CGG C-3'; and Rh-1, 5'-GAG GAA TTC CCA GAG GAC TCT GG-3'. Mice expressing the truncated opsin were identified by PCR analysis as described (20) .
Homozygous affected rd/rd mice were identified by screening for the rd allele by PCR amplification across a nonsense mutation that creates a DdeI site in the phosphodiesterase (PDE) 83-subunit cDNA (21) .
DNA Laddering Assay. After euthanasia, eyes were enucleated and retinas removed. Total genomic DNA was extracted from the retina and size-fractionated in a 1.5% agarose gel, blotted, and probed with 32p labeled mouse genomic DNA.
Tissue Processing for Light Microscopy, Immunocytochemistry, and Photoreceptor Morphometry. The procedures were carried out as described (22) . Bcl-2 antibody was a monoclonal antibody purchased from Cambridge Research Biochemicals in 1-,um plastic-embedded sections using a calibrated measuring reticule. Surviving PRs were counted in a 180-,um linear expanse of central retina.
Light Damage and Statistical Analysis. Albino bcl-2 positive mice (bcl-2/+) of the lower expressing b line were crossed to albino BALB/c ByJ mice producing '50% each of bcl-2 positive (bcl-2/+) and wild-type (+/+) progeny. At 2-6 months of age, the mice were ear-punched for identification 2 days before constant light exposure, and genomic DNA was prepared from tail samples to determine the presence or absence of the bcl-2 transgene in the mice. At the same time, one eye was removed with the mice under Avertin anesthesia and immersion-fixed to determine the effect of the bcl-2 transgene on PRs in normal cyclic light. Monocular enucleation has no measurable effect on constant light damage to the remaining eye (M.M.L., unpublished observations). Some of the albino bcl-2 positive mice (bcl-2/+) were crossed to each other to give homozygous wild-type, bcl-2/ + and bcl-2/bcl-2 genotypes for light damage studies to determine the effect of two copies of the bcl-2 transgene on retinal PRs both in cyclic light and constant light.
Mice bred for light damage studies were placed into continuous fluorescent lighting at an illuminance of 115-130 ft-c for 14 days, which typically reduces the PR outer nuclear layer (ONL) to 1 row or less of PR nuclei in the most sensitive region in the superior hemisphere of the eye as described (23, 24) . Histologic sections cut along the vertical meridian were scored by four observers for the degree of potential rescue on a scale of 1 (severe damage with little or no rescue) to 5 (small amount of damage to the ONL, with about 75-85% of PR nuclei remaining). The scores were done with the observers unaware of the bcl-2 genotype and were based on ONL thickness in different regions of the eye, as well as PR inner and outer segment length and integrity. In general, scores of 1-3 represent the typical range of degeneration seen after 14 days of continuous light in BALB/c mice, which corresponds to a mean ONL thickness of <5-20 ,um, as described (23) . Differences in the scores of the different genotypes were compared by using the Student's t test and analysis of variance statistical measures.
RESULTS

Generation ofTransgenic Mice with a Murine Opsin Promoter
Fused to Human bc1-2 cDNA. We made two lines of transgenic mice in which PRs overexpressed human bcl-2 by using the murine opsin promoter (22) . Two founders (lines b and c) expressed different levels of human bcl-2 as determined by protein immunoblotting (Fig. 1A) . A densitometric scan of the immunoblots demonstrated an 8-fold greater level of Bcl-2 protein in transgenic line c compared with line b. In nontransgenic siblings, endogenous Bcl-2 was undetectable with an antibody against an epitope common to mouse and human. This confirms the previous finding of low-level expression of the endogenous Bcl-2 gene in the rat retina (25) . We examined the distribution of Bcl-2 in lines b and c by light and electron microscope immunocytochemistry. Expressed Bcl-2 protein was localized exclusively to PRs (Fig. 1C) , with most of the Bcl-2 immunoreactivity in the rod synaptic terminals (Fig. 1B) . Bcl-2 immunoreactivity was associated with vesicles in the terminal region above the active zone (26) , and not associated with the prominent mitochondria or synaptic ribbon in this region.
High Level bcl-2 Expression Causes Apoptosis in Photoreceptors. PR cell death was observed in transgenic mice from line c beginning in the second postnatal week. By postnatal day 24, PR outer segments were disorganized in line c (Fig. 2C) . PR cell death continued with age in this line, until at 3 months 75% of the PRs were lost (Fig. 2F) . At 6 months, only a single layer of PR nuclei remained (Fig. 2I) .
Line b expressed an 8-fold lower level of bcl-2, and morphological differences were not observed between this line and the wild-type retina in the first postnatal month (compare Fig.  2 B and A). Increased PR apoptosis in line b was observed, however, in the months that followed, albeit at a much slower rate than in line c (compare. Fig. 2 B and E to A and D, respectively). A slight thinning of the PR layer ("20%) was evident by 6 months of age in line b (compare Fig. 2 (bcl-2/-and S334ter/-). Mice from both bcl-2 transgenic lines b and c were crossed, and no discernible differences between these two lines were observed. Overexpression of bcl-2 reduced apoptotic cell death in the retina of mice expressing truncated opsin by >80% in the initial 2 postnatal weeks (Fig. 3 ). Numerous cells with uniform nuclear staining with 4',6-diamidino-2-phenylindole (DAPI) were present in the PR layer of the retina expressing the mutant rhodopsin.
The cells that have not released the nuclease showed heterochromatic nuclear staining. In contrast, the retina of siblings heterozygous for bcl-2 and S334ter had few apoptotic nuclei.
The thickness of the PR cell layer was similar to wild-type siblings, and most PR nuclei showed the heterochromatic staining pattern characteristic of a living cell (data not shown). (Fig. 3D) . The effect of bcl-2 on apoptosis was temporary, as the PRs continued to degenerate, but at a reduced rate. Animals from the b line were used to study the long term effect of bcl-2 on cell survival. At 4 postnatal weeks, retinas of mice expressing the mutant opsin alone possessed a single row of PR nuclei. Mice expressing both the mutant opsin and bcl-2 retained about 25% of their original complement of PRs. By 3 months of age, however, the retinal morphology of the bcl-2 positive S334ter and the S334ter siblings were indistinguishable (data not shown).
bcl-2 Inhibits Photoreceptor Cell Death in rd mice. To examine the effect of bcl-2 on an autosomal recessive retinal degeneration, we crossed bcl-2 positive mice from line b to rd/rd mice. There was a rapid loss of rod PRs between postnatal day 7 and 14 in rd/rd with and without the bcl-2 transgene. In this period, '50% of the PRs died by apoptosis (Fig. 4) . This rapid cell death continued in rd/rd mice, reducing the retina to a single layer of cone nuclei by postnatal day 30. There was less cell death in bcl-2 transgenic rd/rd mice (Fig. 4) . At postnatal day 16, rd/rd mice overexpressing bcl-2 had 50% more PRs than nontransgenic littermates, and by day 19, they had several-fold more PRs (Fig.  4) . By postnatal day 40, however, retinas in the rd/rd bcl-2 mice were identical to transgene negative littermates, with few nuclei remaining in the ONL (Fig. 4) . (X 19,000.) (C) Light microscope immunocytochemistry. Bcl-2 immunoreactivity is exclusively localized to the outer plexiform layer of the retina.
(Bar = 25 ,tM.) bcl-2 Protects Photoreceptors from Apoptosis Caused by Constant Light. We studied the effects of bcl-2 overexpression on light damage in albino BALB/c mice. We compared the effects of 14 days of continuous illumination on albino wildtype and transgenic mice. Prior to light damage, mice were reared in cyclic light. Nontransgenic siblings reared in cyclic light had normal retinas with 9-10 rows of PR nuclei in the ONL, and inner and outer segments were of normal length and caliber (Fig. SA) . Fourteen days of constant light caused a severe loss of PRs in these animals. In the most degenerated central region of the superior hemisphere, the ONL was reduced to 0-2 rows of nuclei (Fig. SB) . We scored the degree of degeneration in 52 nontransgenic siblings, and found that the range of degeneration across animals (Fig. SE) was as typically observed in inbred BALB/c mice (27) .
Mice carrying the bcl-2 transgene exhibited subtle degenerative changes in cyclic light as noted above. Thus at 2 months of age, the ONL was reduced to -7-8 rows of nuclei (Fig. SC) , and the number of pyknotic nuclei appeared greater than in normal wild-type littermates. In addition, the PR inner and outer segments were shorter and often more disorganized than normal (compare Fig. S A and C) . Nevertheless, the bcl-2 transgene protected the PRs from the damaging effects of constant light. Typically, 3-S rows of PR nuclei remained in the most degenerated region of the ONL after 14 days of constant light (Fig. SD) . (Fig. SE) (9, 10) . In this model, expression of C-terminal truncated opsin in the PRs rapidly triggers cell death by apoptosis. Damage to the PR likely results from the inability of the cell to appropriately sort the mutant opsin protein in the PRs (16, 17) . Overexpression ofbcl-2 significantly extended the survival of PRs expressing the mutant opsin. At 4 postnatal weeks, transgenic mice expressing both bcl-2 and mutant opsin transgenes showed a 25% reduction in PR cell death.
Similarly, PRs in rd/rd mice overexpressing bcl-2 survived the damaging effects of a defective phosphodiesterase significantly longer than did nontransgenic siblings. In rd/rd mice, a null mutation in the PDE f3 subunit gene leads to a nonfunctional cGMP-PDE enzyme in rods. The deficiency in PDE activity leads to cyclic GMP accumulation that rapidly damages rod PRs (28) . Rods in the rd/rd retina overexpressing bcl-2 survived the damaging effect of elevated cGMP for 2-3 times longer than nontransgenic rd/rd littermates.
There was, however, the same rapid loss of rod PRs between postnatal day 7 and 14 in rd/rd mice carrying the bcl-2 transgene as in nontransgenic siblings. In rd/rd mice without the bcl-2 transgene, this loss of rods continued at a rapid rate until there were no surviving rod cells at postnatal day 30. In bcl-2 overexpressors, however, this rod cell loss lessened between postnatal day 14 and 40. There are several possible explanations for the two phases of cell death. It may be that the amount of bcl-2 provided by the transgene at days 5-14 is insufficient to generate the rescue effect. There may also be multiple mechanisms of cell death at work in the PRs. Answering these questions will require a careful study of the relationship between the bcl-2 level in the receptors and the rescue effect.
Despite the established nature of the genetic defects in these two models, a key unresolved question is how the expression of the mutant opsin or the lack of a functional phosphodiesterase signals the initiation of apoptosis in the PRs. There is no evidence that overexpression of bcl-2 altered the disease mechanism initiated by these genetic defects. However, the action of bcl-2 significantly increased the period in which PRs survived these degenerative processes. jury from Constant days following a 7-day exposure to constant light, the inner generation described segments were healthier and the outer segments had reformed. nage from the mutaSimilarly, we expect that the survival-enhancing effect of bcl-2 were subjected to a will allow PRs to recover and regenerate outer segments, but expressing bcl-2 disthis remains to be shown. S { * a , t --m s r s 9 J s s ' i , * . , , . ' 1 . . * . b ' f . , + . , : s : . . . . . . . . . of the bcl-2 transgene itself, it clearly protects PRs from genetic and environmental insults. These results strongly support the idea that blocking the entry of PRs into apoptosis may delay or prevent retinal degeneration.
